US Patent 7879358 Pulmonary delivery for levodopa
Patent 7879358 was granted and assigned to Alkermes (company) on February, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+373 characters)
Article
Patent abstract
In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Blair Jackson0
David J. Bennett0
Dwaine F. Emerich0
Raymond T. Bartus0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07879358 Pulmonary delivery for levodopa US Patent 7879358 Pulmonary delivery for levodopa
Infobox
Patent Number
07879358
Patent Number
7879358
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07879358 Pulmonary delivery for levodopa
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07879358
Date of patent
February 1, 2011
Patent application number
10392342
Date Filed
March 19, 2003
Patent primary examiner
Find more entities like US Patent 7879358 Pulmonary delivery for levodopa
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.